The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.
The global Dermatological Drugs market was valued at US$ 24370 million in 2023 and is anticipated to reach US$ 33730 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dermatological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Drugs.
Report Scope
The Dermatological Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Johnson & Johnson
- Merck
- Bayer
- Mylan Pharmaceuticals
- Pfizer
- F. Hoffmann-La Roche
- Allergan
- Valeant Pharmaceuticals
- PharmaDerm Pharmaceuticals
- Allergan Inamed Corporation
Segment by Type
- Prescription-Based Drugs
- Over-the-Counter Drugs
Segment by Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dermatological Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dermatological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Dermatological Drugs Market Overview
1.1 Product Overview and Scope of Dermatological Drugs
1.2 Dermatological Drugs Segment by Type
1.2.1 Global Dermatological Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Prescription-Based Drugs
1.2.3 Over-the-Counter Drugs
1.3 Dermatological Drugs Segment by Application
1.3.1 Global Dermatological Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Dermatological Drugs Market Size Estimates and Forecasts
1.4.1 Global Dermatological Drugs Revenue 2019-2030
1.4.2 Global Dermatological Drugs Sales 2019-2030
1.4.3 Global Dermatological Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dermatological Drugs Market Competition by Manufacturers
2.1 Global Dermatological Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dermatological Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dermatological Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Dermatological Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermatological Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermatological Drugs, Product Type & Application
2.7 Dermatological Drugs Market Competitive Situation and Trends
2.7.1 Dermatological Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dermatological Drugs Players Market Share by Revenue
2.7.3 Global Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dermatological Drugs Retrospective Market Scenario by Region
3.1 Global Dermatological Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dermatological Drugs Global Dermatological Drugs Sales by Region: 2019-2030
3.2.1 Global Dermatological Drugs Sales by Region: 2019-2024
3.2.2 Global Dermatological Drugs Sales by Region: 2025-2030
3.3 Global Dermatological Drugs Global Dermatological Drugs Revenue by Region: 2019-2030
3.3.1 Global Dermatological Drugs Revenue by Region: 2019-2024
3.3.2 Global Dermatological Drugs Revenue by Region: 2025-2030
3.4 North America Dermatological Drugs Market Facts & Figures by Country
3.4.1 North America Dermatological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dermatological Drugs Sales by Country (2019-2030)
3.4.3 North America Dermatological Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dermatological Drugs Market Facts & Figures by Country
3.5.1 Europe Dermatological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dermatological Drugs Sales by Country (2019-2030)
3.5.3 Europe Dermatological Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermatological Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Dermatological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dermatological Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Dermatological Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dermatological Drugs Market Facts & Figures by Country
3.7.1 Latin America Dermatological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dermatological Drugs Sales by Country (2019-2030)
3.7.3 Latin America Dermatological Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermatological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermatological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dermatological Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dermatological Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dermatological Drugs Sales by Type (2019-2030)
4.1.1 Global Dermatological Drugs Sales by Type (2019-2024)
4.1.2 Global Dermatological Drugs Sales by Type (2025-2030)
4.1.3 Global Dermatological Drugs Sales Market Share by Type (2019-2030)
4.2 Global Dermatological Drugs Revenue by Type (2019-2030)
4.2.1 Global Dermatological Drugs Revenue by Type (2019-2024)
4.2.2 Global Dermatological Drugs Revenue by Type (2025-2030)
4.2.3 Global Dermatological Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Dermatological Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dermatological Drugs Sales by Application (2019-2030)
5.1.1 Global Dermatological Drugs Sales by Application (2019-2024)
5.1.2 Global Dermatological Drugs Sales by Application (2025-2030)
5.1.3 Global Dermatological Drugs Sales Market Share by Application (2019-2030)
5.2 Global Dermatological Drugs Revenue by Application (2019-2030)
5.2.1 Global Dermatological Drugs Revenue by Application (2019-2024)
5.2.2 Global Dermatological Drugs Revenue by Application (2025-2030)
5.2.3 Global Dermatological Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Dermatological Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Dermatological Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Dermatological Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Dermatological Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Corporation Information
6.4.2 Mylan Pharmaceuticals Description and Business Overview
6.4.3 Mylan Pharmaceuticals Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Pharmaceuticals Dermatological Drugs Product Portfolio
6.4.5 Mylan Pharmaceuticals Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Dermatological Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 F. Hoffmann-La Roche Dermatological Drugs Product Portfolio
6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
6.7 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Dermatological Drugs Product Portfolio
6.7.5 Allergan Recent Developments/Updates
6.8 Valeant Pharmaceuticals
6.8.1 Valeant Pharmaceuticals Corporation Information
6.8.2 Valeant Pharmaceuticals Description and Business Overview
6.8.3 Valeant Pharmaceuticals Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Valeant Pharmaceuticals Dermatological Drugs Product Portfolio
6.8.5 Valeant Pharmaceuticals Recent Developments/Updates
6.9 PharmaDerm Pharmaceuticals
6.9.1 PharmaDerm Pharmaceuticals Corporation Information
6.9.2 PharmaDerm Pharmaceuticals Description and Business Overview
6.9.3 PharmaDerm Pharmaceuticals Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PharmaDerm Pharmaceuticals Dermatological Drugs Product Portfolio
6.9.5 PharmaDerm Pharmaceuticals Recent Developments/Updates
6.10 Allergan Inamed Corporation
6.10.1 Allergan Inamed Corporation Corporation Information
6.10.2 Allergan Inamed Corporation Description and Business Overview
6.10.3 Allergan Inamed Corporation Dermatological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Allergan Inamed Corporation Dermatological Drugs Product Portfolio
6.10.5 Allergan Inamed Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermatological Drugs Industry Chain Analysis
7.2 Dermatological Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermatological Drugs Production Mode & Process
7.4 Dermatological Drugs Sales and Marketing
7.4.1 Dermatological Drugs Sales Channels
7.4.2 Dermatological Drugs Distributors
7.5 Dermatological Drugs Customers
8 Dermatological Drugs Market Dynamics
8.1 Dermatological Drugs Industry Trends
8.2 Dermatological Drugs Market Drivers
8.3 Dermatological Drugs Market Challenges
8.4 Dermatological Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
